whitepaper
Paper: Acquisition and reversal of visual learning in CVN mice
Peer-reviewed paper on how touchscreen testing is a translational tool to assess cognitive function in a mouse model of Alzheimer’s disease...
List view / Grid view
Informatics
news
Artificial Medical Intelligence to introduce medical record tech
AMI has released the full version of HCC Coding as part of the EMscribe suite of tools in support of medical records processing and abstraction.
news
Research database to help promote pharma/academic collaborations
The ABPI has developed a new tool to help build research relationships between the pharmaceutical industry and UK academics.
news
New blood test uses nanotechnology to predict prostate cancer
A new diagnostic will allow men to bypass painful biopsies to test for aggressive prostate cancer.
news
Artificial intelligence to assist in the treatment of heart patients
Artificial intelligence can be used to recognise difficult to predict complications as early as possible within the home care of heart patients.
whitepaper
Application note: The reliability of assay-ready plates for cell-based screening enabled by the Echo® 550 Liquid handler
In this application note, Sheraz Gul (Fraunhofer-IME SP), Markus Wolf (Fraunhofer-IME SP), Enda O’Connell (National University of Ireland Galway) and Howard Fearnhead (National University of Ireland Galway), demonstrate that the Echo 550 Liquid Handler can precisely and accurately transfer nanolitre volumes of compound with acoustic energy in a completely contact-free…
news
SOPHiA artificial intelligence empowers liquid biopsies to fight cancer
Sophia Genetics injects artificial intelligence in liquid biopsies to accelerate early detection of cancer and monitor treatments’ effectiveness.
news
Eisai and Charles River Laboratories announce extension of integrated drug discovery partnership
Companies to continue collaboration in discovery of next generation anti-malaria drugs...
article
Using native mass spectrometry to inform drug discovery
Mass spectrometry (MS) performed under native-like conditions (nMS) is a promising approach for studying protein-drug interactions, and has already informed treatments of some of the most intractable diseases including cancer, diabetes and Alzheimer’s.
news
Human Cell Atlas data platform kicks off with support from CZI
The Chan Zuckerberg Initiative announced financial support for the Human Cell Atlas, which uses sequencing technology to redefine every cell in the body...
news
SOPHiA AI unlocks power of exome sequencing for clinical diagnostics
SOPHiA AI demystifies the secrets of the exome, home to 85% of disease-causing genetic variants. Clinicians can now get highly accurate results to diagnose patients for rare hereditary disorders.
news
CRISPR gene editing can cause hundreds of unintended mutations
As CRISPR-Cas9 starts to move into clinical trials, a new study has found that the gene-editing technology can introduce hundreds of unintended mutations into the genome.
news
Making biological drugs with spider silk protein
Researchers at the Karolinska Institutet in Sweden have managed to synthesise lung surfactant, a drug used in the care of preterm babies, by mimicking the production of spider silk.
news
Flexible new method for early cancer diagnosis
Investments are now being made to roll out this innovation across healthcare and broaden the scope of the research in this field.
news
Blood test offers improved breast cancer detection tool to reduce use of breast biopsy
Study shows 'liquid biopsy' after abnormal mammogram and other imaging can help rule out breast cancer, reduce breast biopsy by up to 67% in women...
